Impact of COVID-19 Pandemic on Hepatopancreatobiliary Surgical Services in Singapore

NCT05572866 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1089

Last updated 2022-10-10

No results posted yet for this study

Summary

This paper is intended to report our observational study in evaluating the impact of the COVID-19 pandemic on Tan Tock Seng Hospital hepatopancreatobiliary unit's surgical workload from January to June across 2019 to 2022, corresponding to the pre-pandemic baseline to its peak and the gradual normalization of hospital services as Singapore entered the transition phase to COVID-19 resilience.

Conditions

Interventions

OTHER

COVID-19 pandemic

To retrospectively review the surgical volume across 2019-2022 to see the impact of the COVID-19 pandemic.

Sponsors & Collaborators

  • Tan Tock Seng Hospital

    lead OTHER

Principal Investigators

  • Vishalkumar G Shelat, MMed, FRCS · Tan Tock Seng Hospital

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05572866 on ClinicalTrials.gov